Effectiveness of radiotherapy for patients with indolent non-Hodgkin's lymphoma

被引：0
作者：
Hadi, I. [1 ]
Schummer, A. [1 ]
Eze, C. [1 ]
Dreyling, M. [2 ]
Belka, C. [1 ]
Li, M. [1 ]
机构：
[1] Univ Hosp LMU, Dept Radiat Oncol, Munich, Germany
[2] Univ Hosp LMU, Dept Oncol, Munich, Germany
来源：
RADIOTHERAPY AND ONCOLOGY | 2020年 / 152卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO-0913
引用
收藏
页码：S487 / S488
页数：2
相关论文
共 50 条
[41]   Rituxan delays disease progression in indolent non-Hodgkin's lymphoma [J].
不详 .
ONCOLOGY-NEW YORK, 2002, 16 (11) :1472-1472
[42]   Antibody and immunomodulatory agents in the treatment of indolent non-Hodgkin's lymphoma [J].
LaCasce, Ann S. ;
Freedman, Arnold S. .
SEMINARS IN HEMATOLOGY, 2008, 45 (02) :85-89
[43]   A systematic overview of chemotherapy effects in indolent non-Hodgkin's lymphoma [J].
Brandt, L ;
Kimby, E ;
Nygren, P ;
Glimelius, B .
ACTA ONCOLOGICA, 2001, 40 (2-3) :213-223
[44]   Cladribine and mitoxantrone dose escalation in indolent non-Hodgkin's lymphoma [J].
Saven, A ;
Lee, T ;
Kosty, M ;
Piro, L .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (07) :2139-2144
[45]   Optimizing the clinical benefit of rituximab - in indolent non-Hodgkin's lymphoma [J].
不详 .
CLINICAL LYMPHOMA, 2004, 5 (03) :149-151
[46]   Palliative radiotherapy in eyelid non-Hodgkin's lymphoma [J].
Galeazzi, G ;
Di Russo, A ;
Boffi, R ;
De Conno, F .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (23) :4601-4602
[47]   Indolent non-Hodgkin lymphoma primarily involving the hard palate: outcome following radiotherapy [J].
Milgrom, Sarah A. ;
Yahalom, Joachim .
LEUKEMIA & LYMPHOMA, 2013, 54 (06) :1208-1211
[48]   Considerations with newer regimens for indolent non-Hodgkin lymphoma [J].
Rummel, Mathias .
CLINICAL LYMPHOMA & MYELOMA, 2008, 8 :S128-S136
[49]   Radiotherapy indications in non-Hodgkin lymphoma [J].
Quero, L. ;
Hennequin, C. ;
Brice, P. .
CANCER RADIOTHERAPIE, 2009, 13 (6-7) :471-478
[50]   Interleukin-6 in patients with aggressive and indolent non-Hodgkin's lymphoma: A predictor of prognosis? [J].
Duletic-Nacinovic, A ;
Sever-Prebelic, M ;
Stifter, S ;
Jonjic, N ;
Hasan, M ;
Labar, B .
CLINICAL ONCOLOGY, 2006, 18 (04) :367-368
12345